ChromaDex (NASDAQ: CDXC) leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. The company also has business units focused on natural product fine chemicals, chemistry and analytical testing services, and product regulatory and safety consulting. ChromaDex discovers and licenses early stage, IP-backed ingredient technologies then utilizes in-house chemistry, regulatory and safety consulting business units to develop commercially viable ingredients. The company’s ingredient portfolio is backed with clinical and scientific research, as well as extensive IP protection and patented ingredient technologies.  For more information, visit the company’s website at www.chromadex.com